These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5688267)

  • 21. Studies on the mode of action of clofibrate: effects on hormone-induced changes in plasma free fatty acids, cholesterol, phospholipids and total esterified fatty acids in rats and dogs.
    Barrett AM; Thorp JM
    Br J Pharmacol Chemother; 1968 Feb; 32(2):381-91. PubMed ID: 4296427
    [No Abstract]   [Full Text] [Related]  

  • 22. [Daily profile of blood lipids under standardized diet with and without nicotinic acid].
    Mühlfellner G; Mühlfellner O; Zöfel P; Kaffarnik H
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():810-2. PubMed ID: 1029288
    [No Abstract]   [Full Text] [Related]  

  • 23. Some effects of 3-chloroisoxazole-5-carboxylic acid on lipid and carbohydrate metabolism.
    Eastwood GR; Kellett DN
    Biochem Pharmacol; 1969 Mar; 18(3):569-77. PubMed ID: 5772587
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of chlorophenoxyisobutyric acid on the release of free fatty acids from isolated adipose tissue in vitro.
    Barrett AM
    Br J Pharmacol Chemother; 1966 Feb; 26(2):363-71. PubMed ID: 5912683
    [No Abstract]   [Full Text] [Related]  

  • 25. Lowering of serum lipid levels by "masked" nicotinic acid derivatives.
    Bailey DM; Wood D; Johnson RE; McAuliff JP; Bradford JC; Arnold A
    J Med Chem; 1972 Apr; 15(4):344-8. PubMed ID: 5019547
    [No Abstract]   [Full Text] [Related]  

  • 26. Lowering of blood ketone bodies induced by drugs preventing free fatty acid mobilization.
    Bizzi A; Tacconi MT; Garattini S
    Experientia; 1966 Oct; 22(10):664. PubMed ID: 5971915
    [No Abstract]   [Full Text] [Related]  

  • 27. The physiology and pharmacology of adipose tissue lipolysis: its inhibition and implications for the treatment of diabetes.
    Froesch ER
    Diabetologia; 1967 Dec; 3(6):475-87. PubMed ID: 5620807
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of nicotinic acid and beta-adrenergic blockade on lipid mobilization during prolonged irradiation of rats].
    Ahlersová E; Ahlers I; Sedláková A; Malatová Z; Praslicka M
    Radiobiologiia; 1973; 13(1):113-6. PubMed ID: 4719870
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of methylpyrazole-carboxylic acid on carbohydrate and lipid metabolisms in patients with diabetes mellitus].
    Lang PD; Wahl P; Hassalacher Ch; Vollmar J
    Arzneimittelforschung; 1975 Jan; 25(1):117-20. PubMed ID: 807221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of lipid transport and deposition. Effects of nicotinic acid. SAM-TR-68-5.
    Paoletti R
    Tech Rep SAM-TR; 1967 Jul; ():1-12. PubMed ID: 5301163
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute effects on plasma lipids in the rat of a new long-acting nicotinic acid derivative: LG 13979.
    Subissi A; Criscuoli M; Biagi M; Murmann W
    J Pharm Pharmacol; 1983 Sep; 35(9):571-5. PubMed ID: 6138406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antilipolysis as a tool in the study of clinical and experimental diabetes. Lecture for the 1968 Minkowski Award.
    Carlson LA
    Diabetologia; 1969 Dec; 5(6):361-5. PubMed ID: 4313598
    [No Abstract]   [Full Text] [Related]  

  • 33. [Inhibitors of the mobilization of free fatty acids].
    Garattini S; Bizzi A
    Actual Pharmacol (Paris); 1969; 22():169-89. PubMed ID: 4323507
    [No Abstract]   [Full Text] [Related]  

  • 34. Observations on some pharmacologic properties of a new ester of the nicotinic acid: mesoinositol-pentanicotinate.
    Linari G
    Arzneimittelforschung; 1972 Aug; 22(8):1419-21. PubMed ID: 4678404
    [No Abstract]   [Full Text] [Related]  

  • 35. Correlation between the plasma concentration of free nicotinic acid and some of its pharmacological effects in the fasted rat after an oral dose of sorbinicate and of nicotinic acid.
    Subissi A; Murmann W
    Arzneimittelforschung; 1978; 28(7):1143-5. PubMed ID: 582703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Arteriosclerosis--nicotinic acid therapy. 12. Some effects on experimental animals].
    Brattsand R; Lindström E
    Lakartidningen; 1971 Apr; 68(15):1776-82. PubMed ID: 4325229
    [No Abstract]   [Full Text] [Related]  

  • 37. Blockers of free fatty acid release and postprandial lipemia.
    Barboriak JJ; Meade RC; Owenby J; Stiglitz RA
    Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):249-54. PubMed ID: 5715403
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of nicotinic acid on the serum lipids of normal and of thyroidectomized dogs.
    Grande F
    Metabolism; 1966 Jul; 15(7):661-71. PubMed ID: 5918362
    [No Abstract]   [Full Text] [Related]  

  • 39. The hypersensitivity of adipose tissue to norepinephrine and other lipolytic agents during blockade of free fatty acids (FFA) mobilization.
    Bizzi A; Codegoni AM; Garattini S
    Biochem Pharmacol; 1969 Sep; 18(9):2053-60. PubMed ID: 4310274
    [No Abstract]   [Full Text] [Related]  

  • 40. Subacute administration of pentaerythritoltetranicotinate (Perycit) to man.
    Harthon L; Svedmyr N
    Atherosclerosis; 1974; 20(1):65-8. PubMed ID: 4617581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.